Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital.
about
Vaccines for preventing influenza in healthy adultsVaccines for preventing influenza in healthy childrenVaccines for preventing influenza in healthy adultsVaccines for preventing influenza in healthy childrenVaccines for preventing influenza in healthy adultsSerial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.Ecological and immunological determinants of influenza evolution.Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis.Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009-10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals.Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic.Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination.Development of a vaccine against pandemic influenza viruses: current status and perspectives.Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza virusesInfluence of prior influenza vaccination on antibody and B-cell responses.Three year follow up study of national influenza vaccination practices in Japan.Comparative Safety and Efficacy Profile of a Novel Oil in Water Vaccine Adjuvant Comprising Vitamins A and E and a Catechin in Protective Anti-Influenza Immunity.Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals.Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.Leishmaniasis: current status of vaccine developmentOral administration of influenza vaccine in combination with the adjuvants LT-K63 and LT-R72 induces potent immune responses comparable to or stronger than traditional intramuscular immunizationIntranasal immunization of mice with influenza vaccine in combination with the adjuvant LT-R72 induces potent mucosal and serum immunity which is stronger than that with traditional intramuscular immunization.Dynamics and selection of many-strain pathogens.Failure of influenza vaccine to prevent two successive outbreaks of influenza A H1N1 in a school community.Can successful vaccines teach us how to induce efficient protective immune responses?Rehabilitation in psychiatric conditions: 2--Psychological approaches and support, the family, and activities.Lung homing CTLs and their proliferation ability are important correlates of vaccine protection against influenzaProtection by a polyvalent influenza vaccine and persistence of homologous and heterologous HI antibodies during a period of two epidemic seasons.Strain specificity of serum antibody to the haemagglutinin of influenza A (H3N2) viruses in children following immunization or natural infection.Humoral and cellular responses of mice to infection with a cold-adapted influenza A virus variantDose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.Sequential infection or immunization of ferrets with a series of influenza A (H3N2) strains (report to the Medical Research Council's Sub-Committee on influenza Vaccines (CDVIP/IV)).Concurrent outbreaks of influenza and parvovirus B19 in a boys' boarding schoolA review of outbreaks of infectious disease in schools in England and Wales 1979-88Variable efficacy of repeated annual influenza vaccinationInfectivity and reactogenicity of reassortant cold-adapted influenza A/Korea/1/82 vaccines obtained from the USA and USSR.Influenza: diagnosis, management, and prophylaxis.Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccineDevelopment and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine.Agent-based modeling of host-pathogen systems: The successes and challenges.
P2860
Q24197955-6C91E40A-CF36-470E-8FEB-A44125F686A3Q24201525-F8BE5D4D-DA22-405B-9445-92DBB68E984CQ24234114-873F8AD0-E918-4607-B296-8F9C9F90E8E6Q24243174-5352DF4D-5719-4533-85ED-922867C0C842Q24245429-5B1B368E-029E-4FE1-92D2-7D5BFD59222DQ30151372-0B30FC35-7B8F-4FAC-ACD2-8D687CFF4311Q30332657-E6744ACC-38C1-46B9-9DD5-E7DE45F55450Q30352862-3356BC88-5D14-4117-A85B-FED2B9DC6168Q30360610-5A3BC383-C818-470C-869F-F9E7F608F1AFQ30360869-9A53A18A-CDCD-494A-AA03-7D08FF3E440EQ30368005-1D30908D-64DB-4A28-A3E9-AFA4AD373E0BQ30373784-9F34B413-E1A2-442A-B66C-2C4DFF8AEF93Q30377017-76E9CE6D-6BF1-4D8A-ACF7-2F5E38093A34Q33361605-F6F2220E-54B9-45CF-A9B8-D8AFE5EEDEB6Q33702216-9F469ADE-DAFA-4DEF-9CA2-8D45B4FB147DQ33749602-346C1104-5739-4A88-9512-B488354F9AE1Q33870216-3D566A86-925B-4C8B-9FF8-49B9AB00422BQ33912830-EE60904F-D9F1-48A6-975E-0B431B9806C1Q33941719-1FC00018-254A-41EC-B218-AA66AFB9AA50Q33999182-C69E7169-4771-4E91-B1D8-BAB7E322755FQ34001562-F62F3769-7DF1-49A2-B2DD-1DB75E60352EQ34164563-1A5D3FD5-31B7-4834-82F3-8AFB984A73A3Q34367723-E3375DAD-A444-401F-8E0D-337E8A4707A8Q34409182-95DD7F3C-D1D5-4877-A44A-7EBC5B967217Q34491025-9048D24A-F4E8-4AFD-B026-79AB332BFBCEQ35720693-32F901F5-1D6C-4743-BD44-FABA6073E5D4Q36257566-C00BA4FC-74DF-4485-ACD4-CEAC9AD5071FQ36257993-FE61A4E9-63F3-4C7C-AC0D-777FF8D0FF36Q36335534-CC4DE576-D2C4-45D0-BBBC-D41778FBCB2CQ36348455-C2121CA3-7541-4995-822F-5762E1A5608FQ36472674-4F63AD7E-3E2E-4BE5-A3CA-AC603593DBB5Q36473377-7433EF33-3336-495D-AA51-55013909CD72Q36505280-B606A9D8-285E-4D1E-B6A4-B2124A0C7748Q36705674-E85D98A3-0750-412C-AEC5-CC1F2D287431Q36799346-F1D6CDEE-057E-489E-8A59-5698189F9BB1Q36885662-C1276EE1-6419-4694-8133-BC6875A9C9D6Q36889707-65AFF88D-7A3A-425C-AC1C-2CC4B012ED99Q37200967-05516DCA-9510-4FA2-9F07-E8C91F368BAFQ37200987-86AF3324-D461-481E-BDBA-4465F82C082DQ37318609-8E6F047E-F125-470C-8891-D6FA93DD969D
P2860
Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Assessment of inactivated infl ...... luenza A at Christ's Hospital.
@en
Assessment of inactivated infl ...... luenza A at Christ's Hospital.
@nl
type
label
Assessment of inactivated infl ...... luenza A at Christ's Hospital.
@en
Assessment of inactivated infl ...... luenza A at Christ's Hospital.
@nl
prefLabel
Assessment of inactivated infl ...... luenza A at Christ's Hospital.
@en
Assessment of inactivated infl ...... luenza A at Christ's Hospital.
@nl
P2093
P1433
P1476
Assessment of inactivated infl ...... luenza A at Christ's Hospital.
@en
P2093
C L Miller
J R Davies
T W Hoskins
P356
10.1016/S0140-6736(79)90468-9
P407
P577
1979-01-01T00:00:00Z